Selskabets formål er, direkte eller indirekte, at drive virksomhed i ind- og udland ved industri, handel, finansiering, investering og anden hermed i forbindelse stående virksomhed.
| Year | Revenue | Profit/Loss | Total Assets | Equity | Employees | Report |
|---|---|---|---|---|---|---|
| 2025 | 226.8 mio. | 74.3 mio. | 798.7 mio. | 642 mio. | 0 | |
CVR: 27559522
Pasquale della Puca joined as director
Melanie Hammerschmidt-Broman left as director
Companies in the same industry and area
CVR 33033745
CVR 40341889
CVR 46128168
CVR 45768791
CVR 11772595
Compared to 220 companies in Leasing af intellektuelle ejendomsrettigheder og lignende produkter, dog ikke ophavsretsbeskyttede værker
Comparison is based on industry median values
The financial health of DANAHER MEDICAL ApS appears stable, with consistent profitability over the past five years. Revenue has shown a steady increase from 192.96 million DKK in 2021 to 226.82 million DKK in 2025, while profit has also risen from 55.99 million DKK to 74.27 million DKK in the same period. However, equity has declined significantly from 1.15 billion DKK in 2021 to 642.03 million DKK in 2025, indicating potential concerns regarding financial leverage and long-term sustainability. The company's strong profit margins suggest effective cost management, positioning it favorably within the intellectual property leasing industry.
AI-generated summary
companydata.dk